— Know what they know.
Not Investment Advice

PGNY NASDAQ

Progyny, Inc.
1W: +9.1% 1M: +42.3% 3M: +23.5% YTD: -0.4% 1Y: +19.3% 3Y: -28.8% 5Y: -46.7%
$25.64
+1.04 (+4.23%)
 
Weekly Expected Move ±12.8%
$17 $20 $23 $26 $29
NASDAQ · Healthcare · Medical - Healthcare Information Services · Alpha Radar Strong Buy · Power 70 · $2.0B mcap · 72M float · 2.24% daily turnover · Short 54% of daily vol
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$2.0B
52W Range16.1-28.75
Volume1,962,687
Avg Volume1,609,075
Beta0.91
Dividend
Analyst Ratings
14 Buy 6 Hold 0 Sell
Consensus Buy
Company Info
CEODavid J. Schlanger
Employees675
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2019-10-25
1359 Broadway
New York City, NY 10018
US
212 888 3124
About Progyny, Inc.

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Recent Insider Trades

NameTypeSharesPriceDate
Cummings Melissa B F-InKind 4,172 $16.98 2026-04-14
Clapp Geoffrey F-InKind 3,275 $17.42 2026-03-17
Swartz Allison F-InKind 339 $17.52 2026-03-04
Swartz Allison S-Sale 599 $17.54 2026-03-04
Livingston Mark S. F-InKind 339 $17.52 2026-03-04

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms